Cellebrite DI Ltd. Ordinary Shares (CLBT)

FairStock Score: 49/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Graham-and-Buffett style investor, I ask whether this is a durable business at a sensible price. Cellebrite sells software for legally sanctioned investigations, but the figures I have do not prove a wide moat. In fiscal Q2 2026, revenue was $131.1M and net income was $6.4M, a 4.86% margin. That is thin. The supplied data also indicate profit growth has been negative even as revenue grows, so operating leverage is not yet visible. On the positive side, debt is very low with a D/E of 0.04, and trailing-twelve-month free cash flow was $128.6M, a 4.1% FCF yield. FairStock's Altman Z-Score of 4.48 suggests low bankruptcy risk, and its Piotroski F-Score of 5/9 is middling. The problem is price. At the 2026-10-13 close of $11.38, FairStock calculates a P/E of 49.48, P/B of 5.29, EV/EBITDA of 29.42, and a Graham Number of $3.34. The margin of safety is -240.72%, meaning the quote is far above the Graham-style value. FairStock's ROE is 12.42%, but its ROCE is only 3.92%, so the capital returns are not compelling. This looks like a growing but currently expensive software company with positive cash flow and a strong balance sheet, yet insufficient profitability to justify the multiple on Graham principles. I would want to see margins and return on capital improve before calling it a value opportunity.

In plain English: Cellebrite makes software and services that help law enforcement and other investigators collect and study digital evidence. Sales are growing, but profits are thin and have recently fallen, and the company carries very little debt. Compared with its recent stock price, the shares look expensive relative to its profits and its net assets.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer